食管切除术中个体化围术期血压与液体治疗:前瞻性单盲随机对照试验
该单中心前瞻性盲法随机对照试验将100例食管切除术患者1:1分为延长的目标导向液体治疗组与标准治疗组,前者以患者夜间基线平均动脉压为阈值优化心输出量并持续至次晨7点。结果显示两组第30天综合并发症指数无差异,但干预组液体平衡更高、去甲肾上腺素用量更多、平均动脉压更高。
要点
- 延长至术后的个体化目标导向液体治疗未降低食管切除术后并发症。
- 干预组液体平衡更高、去甲肾上腺素用量更多、平均动脉压更高。
- 第30天综合并发症指数两组无差异。
核心结论
- 延长的个体化目标导向液体治疗未减少食管切除术后并发症。
研究设计与样本
- 单中心前瞻性盲法随机对照试验,100例食管切除术患者1:1随机分组。
主要发现
- 干预组液体平衡为2,517 ± 1,194 ml,标准组为2,001 ± 1,114 ml,平均差516 ml(95% CI 57至974,P = 0.028)。
- 干预组去甲肾上腺素用量中位数7,894 μg(四分位距3,946-13,793),标准组4,611 μg(四分位距2,138-7,296),P < 0.001。
- 干预组平均动脉压平均差3 mmHg(95% CI 1至5,P = 0.011)。
- 第30天综合并发症指数两组分别为39.0 ± 20.0与39.2 ± 21.0,平均差-0.2(95% CI -8.6至8.1,P = 0.95)。
临床怎么用
- 食管切除术围术期采用延长至术后的个体化目标导向液体治疗未显示减少并发症的获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Esophagectomy is a key treatment for esophageal cancer but carries a high risk of postoperative complications, some of which are potentially preventable through optimized hemodynamic management. Goal-directed fluid therapy individualizes cardiac output targets but often applies fixed blood pressure thresholds and is discontinued before major postoperative fluid shifts occur. Extending goal-directed fluid therapy into the postoperative period with individualized blood pressure thresholds may address these limitations. METHODS: In this single-center, prospective, blinded, randomized controlled trial, patients undergoing esophagectomy were randomized 1:1 to either extended goal-directed fluid therapy or standard care. In the extended goal-directed fluid therapy group, cardiac output was optimized and mean arterial pressure threshold was the individual patient's nighttime baseline. The protocol continued from tracheal intubation through to 7:00 am the following morning. The primary outcome was total postoperative morbidity, measured by the Comprehensive Complication Index at day 30. RESULTS: Of 100 patients (49 extended goal-directed fluid therapy group, 51 standard group), extended goal-directed fluid therapy was associated with a higher fluid balance (2,517 ± 1,194 ml vs. 2,001 ± 1,114 ml; mean difference, 516 ml; 95% CI, 57 to 974; P = 0.028), increased norepinephrine use (median, 7,894 μg [interquartile range, 3,946-13,793] vs. 4,611 μg [interquartile range, 2,138 to 7,296]; P < 0.001), and higher mean arterial pressure (mean difference, 3 mmHg; 95% CI, 1 to 5; P = 0.011). At day 30, the mean Comprehensive Complication Index did not differ between groups (39.0 ± 20.0 vs. 39.2 ± 21.0; mean difference, -0.2; 95% CI, -8.6 to 8.1; P = 0.95). CONCLUSIONS: Despite achieving protocol-driven treatment differences, extended and individualized goal-directed fluid therapy did not reduce postoperative complications after esophagectomy.
引用
- Hovgaard HL, Vistisen ST, Enevoldsen J, et al. Individualized Perioperative Blood Pressure and Fluid Therapy in Esophagectomy: A Prospective, Single-blind Randomized Controlled Trial. Anesthesiology. 2025. PMID: 41452340. doi:10.1097/ALN.0000000000005919
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。